Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
California Institute for Biomedical Research
Headquarters: La Jolla, CA, United States of America
Website: http://www.calibr.org
Year Founded: 2012
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Feb 10, 2021
Deals
CRISPR play Caribou broadens therapeutics reach with AbbVie deal to develop allogeneic CAR Ts
After giving up rights to CRISPR-Cas9 for most therapeutic applications years ago, Jennifer Doudna-founded Caribou is now teaming up with AbbVie to use a different CRISPR enzyme to create allogeneic
BioCentury | Aug 23, 2019
Clinical News
Aug. 22 Clinical Quick Takes: Rituximab biosimilar meets endpoint; plus Aimmune, NKMax, Calibr
BioCentury | Jul 25, 2019
Distillery Therapeutics
A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy
BioCentury | Mar 22, 2019
Targets & Mechanisms
Deconvoluting translation at Scripps
Why Scripps Research's non-profit model is doubling down on target discovery
BioCentury | Mar 19, 2019
Distillery Therapeutics
New brain-penetrating RIPK2 inhibitor prodrug for GBM
BioCentury | Mar 22, 2018
Translation in Brief
Mining marine metabolites
Sirenas, BMS use AI to discover small molecule microbiome metabolites
Items per page:
1 - 10 of 36